TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
This Quarter Return
+1.62%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.38B
AUM Growth
+$33.2M
Cap. Flow
-$39.1M
Cap. Flow %
-1.64%
Top 10 Hldgs %
40.59%
Holding
153
New
10
Increased
26
Reduced
20
Closed
10

Sector Composition

1 Healthcare 88.83%
2 Real Estate 2.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARDX icon
51
Ardelyx
ARDX
$1.57B
$12.1M 0.5%
1,389,370
ACAD icon
52
Acadia Pharmaceuticals
ACAD
$4.34B
$11.8M 0.48%
363,585
-351,714
-49% -$11.4M
DOC
53
DELISTED
PHYSICIANS REALTY TRUST
DOC
$11.1M 0.46%
530,672
-700,100
-57% -$14.7M
VTR icon
54
Ventas
VTR
$30.7B
$11.1M 0.45%
152,491
-216,775
-59% -$15.8M
EXEL icon
55
Exelixis
EXEL
$9.95B
$11M 0.45%
1,405,420
NTRA icon
56
Natera
NTRA
$23B
$10.6M 0.43%
882,358
PRTK
57
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10.6M 0.43%
762,581
CPHD
58
DELISTED
Cepheid Inc
CPHD
$10.3M 0.42%
333,590
UTHR icon
59
United Therapeutics
UTHR
$17.7B
$9.86M 0.4%
93,100
SBRA icon
60
Sabra Healthcare REIT
SBRA
$4.56B
$9.41M 0.38%
456,190
HRTX icon
61
Heron Therapeutics
HRTX
$204M
$8.89M 0.36%
492,303
+273,303
+125% +$4.93M
CNC icon
62
Centene
CNC
$14.8B
$8.56M 0.35%
240,000
CLLS
63
Cellectis
CLLS
$260M
$8.25M 0.34%
310,250
GLPG icon
64
Galapagos
GLPG
$2.06B
$8.2M 0.33%
147,738
+127,738
+639% +$7.09M
PBYI icon
65
Puma Biotechnology
PBYI
$258M
$7.75M 0.32%
260,200
CTMX icon
66
CytomX Therapeutics
CTMX
$350M
$7.72M 0.32%
756,090
+428,031
+130% +$4.37M
CYNA
67
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$7.71M 0.31%
460,207
+279,800
+155% +$4.69M
ITCI
68
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.29M 0.3%
187,800
WMGI
69
DELISTED
Wright Medical Group Inc
WMGI
$7M 0.29%
+402,950
New +$7M
JUNO
70
DELISTED
Juno Therapeutics, Inc.
JUNO
$7M 0.29%
182,000
AKRX
71
DELISTED
Akorn, Inc.
AKRX
$6.99M 0.29%
245,235
ELGX
72
DELISTED
Endologix Inc
ELGX
$6.87M 0.28%
55,100
AVDL
73
Avadel Pharmaceuticals
AVDL
$1.45B
$6.71M 0.27%
624,288
PVLA
74
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$6.2M 0.25%
48,102
FOMX
75
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$6.14M 0.25%
966,065